January 12, 2021

AELIX Therapeutics

AElix logo - Ysios Capital

Aelix Therapeutics was a clinical stage company developing a vaccine to treat HIV infection.  AELIX’s HTI HIV vaccine investigational assets have been acquired by Gilead Sciences.

AELIX Therapeutics
Parc Científic de Barcelona
Baldiri i Reixac 4-8
Barcelona, 08028
www.aelixtherapeutics.com